118 related articles for article (PubMed ID: 34081055)
1. Incidental Finding of a Parotid Basal Cell Adenoma With High Tracer Uptake on 68Ga-DOTATOC PET/CT.
Pinot F; Uguen A; Leclere JC; Thuillier P; Abgral R
Clin Nucl Med; 2021 Jul; 46(7):e381-e383. PubMed ID: 34081055
[TBL] [Abstract][Full Text] [Related]
2. Warthin Tumor Incidentally Detected on PET/CT Showing Both 68Ga-DOTANOC and 18F-FDG Uptake.
Vaz SC; Marques A; Lourenço J; Galzerano A
Clin Nucl Med; 2021 Feb; 46(2):e118-e120. PubMed ID: 32956121
[TBL] [Abstract][Full Text] [Related]
3. 68Ga-DOTATATE PET/CT Uptake in Prostate With an Incidental Finding of Prostatic Acinar Adenocarcinoma and Metastatic Neuroendocrine Cancer to the Liver.
Nisar MU; Costa DN; Jia L; Öz OK; de Blanche L
Clin Nucl Med; 2021 Aug; 46(8):e428-e430. PubMed ID: 34034323
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous 68Ga-DOTATOC PET/MRI in patients with gastroenteropancreatic neuroendocrine tumors: initial results.
Beiderwellen KJ; Poeppel TD; Hartung-Knemeyer V; Buchbender C; Kuehl H; Bockisch A; Lauenstein TC
Invest Radiol; 2013 May; 48(5):273-9. PubMed ID: 23493121
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of feasibility and image quality of 68Ga-DOTATOC positron emission tomography/magnetic resonance in comparison with positron emission tomography/computed tomography in patients with neuroendocrine tumors.
Gaertner FC; Beer AJ; Souvatzoglou M; Eiber M; Fürst S; Ziegler SI; Brohl F; Schwaiger M; Scheidhauer K
Invest Radiol; 2013 May; 48(5):263-72. PubMed ID: 23385399
[TBL] [Abstract][Full Text] [Related]
6. Incidental Detection of Retiform Hemangioendothelioma by 68Ga DOTATOC PET/CT.
Vadrucci M; Vandoni A; Gilardi L
Clin Nucl Med; 2017 Feb; 42(2):149-151. PubMed ID: 27997421
[TBL] [Abstract][Full Text] [Related]
7. Focal uptake of 68Ga-DOTATOC in the pancreas: pathological or physiological correlate in patients with neuroendocrine tumours?
Al-Ibraheem A; Bundschuh RA; Notni J; Buck A; Winter A; Wester HJ; Schwaiger M; Scheidhauer K
Eur J Nucl Med Mol Imaging; 2011 Nov; 38(11):2005-13. PubMed ID: 21792572
[TBL] [Abstract][Full Text] [Related]
8. Incidental Uptake in Benign Gynecomastia on 68Ga-DOTATATE PET/CT.
Pandika V; Covington MF
Clin Nucl Med; 2019 Oct; 44(10):799-800. PubMed ID: 30985420
[TBL] [Abstract][Full Text] [Related]
9. Incidental 68Ga-DOTATOC PET/CT Uptake in Hemorrhagic Transformation of Stroke in a Patient With Cervical Paraganglioma.
Valhondo-Rama R; Rodríguez Gómez JC; Couto Caro R; Cabrera-Martín MN; Carreras Delgado JL
Clin Nucl Med; 2021 Dec; 46(12):e565-e566. PubMed ID: 34392278
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous 68Ga-DOTATOC-PET/MRI for IMRT treatment planning for meningioma: first experience.
Thorwarth D; Henke G; Müller AC; Reimold M; Beyer T; Boss A; Kolb A; Pichler B; Pfannenberg C
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):277-83. PubMed ID: 21300465
[TBL] [Abstract][Full Text] [Related]
11. 18F-FDG and 68Ga-DOTATOC PET/CT Findings in a Case of Abdominal Leiomyosarcoma.
Lorusso M; Angelico G; Quirino M; Scolozzi V; Calcagni ML
Clin Nucl Med; 2021 May; 46(5):e270-e272. PubMed ID: 33323743
[TBL] [Abstract][Full Text] [Related]
12. The impact of 68Ga-DOTATOC positron emission tomography/computed tomography on the multimodal management of patients with neuroendocrine tumors.
Frilling A; Sotiropoulos GC; Radtke A; Malago M; Bockisch A; Kuehl H; Li J; Broelsch CE
Ann Surg; 2010 Nov; 252(5):850-6. PubMed ID: 21037441
[TBL] [Abstract][Full Text] [Related]
13. Tumor-Induced Osteomalacia Caused by a Parotid Basal Cell Adenoma Detected by 68Ga-DOTANOC PET/CT.
He Q; Xu Z; Zhang B; Hu W; Zhang X
Clin Nucl Med; 2018 Jun; 43(6):e198-e199. PubMed ID: 29659384
[TBL] [Abstract][Full Text] [Related]
14. Dual-Tracer (68Ga-DOTATOC and 18F-FDG-)-PET/CT Scan and G1-G2 Nonfunctioning Pancreatic Neuroendocrine Tumors: A Single-Center Retrospective Evaluation of 124 Nonmetastatic Resected Cases.
Paiella S; Landoni L; Tebaldi S; Zuffante M; Salgarello M; Cingarlini S; D'Onofrio M; Parisi A; Deiro G; Manfrin E; Bianchi B; Montagnini G; Crinò SF; Bassi C; Salvia R
Neuroendocrinology; 2022; 112(2):143-152. PubMed ID: 33508821
[TBL] [Abstract][Full Text] [Related]
15. 68Ga-DOTATATE PET/CT in Pituitary Carcinoma.
Kaya G; Soydas Turan B; Dagdelen S; Berker M; Tuncel M
Clin Nucl Med; 2021 Dec; 46(12):996-998. PubMed ID: 34269734
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of positron emission tomography imaging using [68Ga]-DOTA-D Phe(1)-Tyr(3)-Octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors.
Kowalski J; Henze M; Schuhmacher J; Mäcke HR; Hofmann M; Haberkorn U
Mol Imaging Biol; 2003; 5(1):42-8. PubMed ID: 14499161
[TBL] [Abstract][Full Text] [Related]
17. Inflammation-Based Index and
Pauwels E; Van Binnebeek S; Vandecaveye V; Baete K; Vanbilloen H; Koole M; Mottaghy FM; Haustermans K; Clement PM; Nackaerts K; Van Cutsem E; Verslype C; Deroose CM
J Nucl Med; 2020 Jul; 61(7):1014-1020. PubMed ID: 31806775
[TBL] [Abstract][Full Text] [Related]
18. Intracavernous Schwannoma Characterized With 18F-FDG, 68Ga-DOTATOC, and 18F-Choline PET.
Farce J; Lecouillard I; Carsin Nicol B; Bretonnier M; Girard A
Clin Nucl Med; 2022 Feb; 47(2):e165-e166. PubMed ID: 34661554
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity Comparison of
Nicolas GP; Schreiter N; Kaul F; Uiters J; Bouterfa H; Kaufmann J; Erlanger TE; Cathomas R; Christ E; Fani M; Wild D
J Nucl Med; 2018 Jun; 59(6):915-921. PubMed ID: 29191855
[TBL] [Abstract][Full Text] [Related]
20. Clinical Assessment of 177Lu-DOTATATE Quantification by Comparison of SUV-Based Parameters Measured on Both Post-PRRT SPECT/CT and 68Ga-DOTATOC PET/CT in Patients With Neuroendocrine Tumors: A Feasibility Study.
Thuillier P; Maajem M; Schick U; Blanc-Beguin F; Hennebicq S; Metges JP; Salaun PY; Kerlan V; Bourhis D; Abgral R
Clin Nucl Med; 2021 Feb; 46(2):111-118. PubMed ID: 33234927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
